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Abstract
Hepatic stellate cell (HSC) lipid droplets are specialized organelles for the storage of retinoid, accounting for 50–60% of all
retinoid present in the body. When HSCs activate, retinyl ester levels progressively decrease and the lipid droplets are lost.
The objective of this study was to determine if the HSC population in a healthy, uninjured liver demonstrates heterogeneity
in its capacity for retinoid and lipid storage in lipid droplets. To this end, we utilized two methods of HSC isolation, which
leverage distinct properties of these cells, including their vitamin A content and collagen expression. HSCs were isolated
either from wild type (WT) mice in the C57BL/6 genetic background by flotation in a Nycodenz density gradient, followed by
fluorescence activated cell sorting (FACS) based on vitamin A autofluorescence, or from collagen-green fluorescent protein
(GFP) mice by FACS based on GFP expression from a GFP transgene driven by the collagen I promoter. We show that GFP-
HSCs have: (i) increased expression of typical markers of HSC activation; (ii) decreased retinyl ester levels, accompanied by
reduced expression of the enzyme needed for hepatic retinyl ester synthesis (LRAT); (iii) decreased triglyceride levels; (iv)
increased expression of genes associated with lipid catabolism; and (v) an increase in expression of the retinoid-catabolizing
cytochrome, CYP2S1. Conclusion: Our observations suggest that the HSC population in a healthy, uninjured liver is
heterogeneous. One subset of the total HSC population, which expresses early markers of HSC activation, may be ‘‘primed’’
and ready for rapid response to acute liver injury.
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Introduction
Retinoids (vitamin A and its metabolites, both natural and
synthetic) are essential to many physiological processes, including
reproduction, embryonic development, bone growth, immunity
and vision [1–3]. Seventy percent of retinoid in the body is stored
in the liver [4,5], and, of this fraction, 90–95% is stored in lipid
droplets within hepatic stellate cells (HSCs) [6]. These lipid
droplets are a distinguishing feature of HSCs and have been
proposed to be specialized organelles for retinoid storage due to
their retinoid content and responsiveness to dietary retinoid status
[7]. Retinyl esters comprise approximately 40% of the lipids
present in these droplets, more than any other single lipid species
[8,9]. And while the remaining 60% is all non-retinoid lipid
species, including triglyceride, cholesterol ester, cholesterol,
phospholipid and free fatty acid, there is considerable data in
the literature suggesting that the formation and maintenance of
these lipid droplets are retinoid-dependent processes [7].
Moriwaki et al. showed that the lipid composition of HSC lipid
droplets is strongly regulated by dietary retinoid status, but not by
dietary triglyceride intake [8]. HSC lipid droplet retinoid lipid
species are decreased in response to a low retinol diet and both
retinoid and non-retinoid lipids are elevated in response to a high
retinol diet; however, neither retinoid nor non-retinoid content is
affected by low or high fat diets. Other data that are highly
suggestive of the role of retinoids in these droplets relates to the
enzyme lecithin:retinol acyltransferase (LRAT), which is the only
known enzyme in the liver capable of synthesizing retinyl ester.
O’Byrne et al. showed that the HSCs of wild type (WT) mice have
large, distinct lipid droplets, but the cells of LRAT-null mice have
none [10]. Thus, the ability to synthesize and store retinyl ester in
HSCs is necessary for the presence of HSC lipid droplets.
It is well-established that when HSCs activate, in response to a
hepatic insult or disease, the HSCs loose their lipid droplet content
and undergo a simultaneous decrease in retinyl ester levels. Leo
and Lieber found that there is a nearly 5-fold decrease in total
hepatic retinol levels with the development of alcoholic hepatitis
and another approximately 4-fold decrease with the development
of cirrhosis [11]. It has also been shown in cultured HSCs that
retinyl ester stored in HSC lipid droplets is first hydrolyzed and
then released into the media as retinol [12]. As HSCs transition
from a quiescent to a myofibroblastic phenotype, they undergo
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increased extracellular matrix production, including increased
synthesis of collagen I, and become fibrogenic [13,14]. It has not
yet been unequivocally determined whether the loss of HSC lipid
droplets is a cause or consequence of activation.
We are interested in understanding the factors that regulate
HSC retinoid storage as retinyl esters in lipid droplets and the
factors that regulate HSC lipid droplet genesis and dissolution. In
this study, we employ two methods of HSC isolation, which
leverage distinct properties of these cells. One method relies on
HSC lipid droplet vitamin A content and the other on HSC
expression of collagen I. It was recently shown that the changes in
gene expression that accompany HSC activation and the loss of
retinyl ester lipid droplets are regulated differently in the in vitro
and in vivo models of activation [15]. Similarly, a goal of this study
is to determine whether different methods of HSC isolation will
yield phenotypically distinct populations of cells and how this may
reflect heterogeneity of HSCs in the liver at a given time. We are
particularly interested in how these populations compare with
regard to their capacities for retinoid storage and lipid droplet
formation. Our findings are presented below.
Materials and Methods
Animals
WT and collagen-green fluorescent protein (GFP) mice were
used, with both strains congenic for the C57BL/6 genetic
background. The collagen-GFP mice have been previously
described [16]. Briefly, a gene construct was made containing
3,122 bp of the a1 (I) collagen (Col1a1) gene promoter linked to the
GFP reporter gene [16]. Hepatic expression of collagen I is solely
in HSCs [17,18], and its expression is increased as the cells
become activated [19,20]. Thus, GFP expression from this
transgene can be used to identify and isolate HSCs. All mice used
in the study were males between 90 and 120 days of age at the
time of sacrifice. Animals were allowed ad libitum access to water
and a standard nutritionally complete rodent chow diet (W. F.
Fisher and Sons, Inc., Somerville, NJ). All mice were maintained
on a 12-h dark-light cycle, with the period of darkness between
7:00 a.m. and 7:00 p.m. in a conventional barrier facility. The
animal experiments described in this report were conducted in
accordance with the National Research Council’s Guide for the
Care and Use of Laboratory Animals and were approved by the
Columbia University Institutional Committee on Animal Care
(IACUC Protocol # AC-AAAA9687).
Hepatic fibrosis induction
WT C57BL/6 mice were given weekly injections of either 0.5 ml
carbon tetrachloride (CCl4) per gram body weight administered in
corn oil or an equivalent volume of corn oil alone for 4 weeks and
then sacrificed. Liver tissue was collected and stored immediately
at 280uC prior to analysis.
Hepatocyte isolations
Livers were perfused in situ with EGTA for 5 min and
collagenase D (0.5 mg/ml, Roche Diagnostics, Indianapolis, IN)
for 15 min, respectively, at a flow rate of 5 ml/min. After
perfusion, the partially digested liver was excised, the digest passed
through a 100 mm nylon mesh to remove undigested materials,
and resuspended in Dulbecco’s Modified Eagle Medium (DMEM;
Gibco, Grand Island, NY) containing 1% penicillin/streptomycin.
Hepatocytes were separated from the non-parenchymal cells and
debris by centrifugation at 4uC in the following sequence: twice for
5 min at 20 g, once for 10 min at 50 g, and twice again for five
min at 20 g. The supernatant was aspirated and the hepatocytes
present in the pellet were resuspended in DMEM. Cell yields were
determined by counting on a hemacytometer.
HSC isolations
Primary mouse HSCs were isolated according to established
protocols [9,21,22]. Briefly, livers were perfused in situ with EGTA
for 5 min, pronase E (0.4 mg/ml, EMD Chemicals Inc., Gibbs-
town, NJ) for 5 min and collagenase D (0.5 mg/ml, Roche
Diagnostics) for 8 min, respectively, at a flow rate of 5 ml/min.
After excision of the liver from the body, the liver digests were
filtered through a cell strainer and washed with Gey’s Balanced
Salt Solution (Sigma, St. Louis, MO) containing DNase I (2 mg/
ml, Roche Diagnostics). For the WT C57 mice, HSCs were
purified from the remainder of non-parenchymal cells and
hepatocyte-derived debris by floatation through 9% (w/v)
Nycodenz (Axis-Shield PoC AS, Oslo, Norway) in Gey’s Balanced
Salt Solution (without NaCl). Subsequently, the cells were
separated by FACS using FACS Calibur (Becton Dickinson,
Franklin Lakes, NJ), and vitamin A auto-fluorescent cells were
collected based on their emission at 460 nm. This method of HSC
isolation yields approximately 10% of the total HSCs estimated to
be in the liver. For the collagen-GFP mice, parenchymal cells and
debris were separated from non-parenchymal cells by centrifuga-
tion at 50 g for 2 minutes. The remaining non-parenchymal cell
suspension was then separated by FACS, and GFP-positive cells
were collected based on their emission at 530 nm. This method of
HSC isolation yields approximately 10% of the total HSCs
estimated to be in the liver.
Isolation of RNA and cDNA synthesis
Total RNA was isolated from HSCs using the Qiagen RNeasy
kit (Qiagen, Valencia, CA). cDNA synthesis and amplification
were performed using the NuGEN WT-Ovation Pico RNA
Amplification kit (NuGEN, San Carlos, CA). The resulting cDNA
was then purified using the Qiagen QIAquick PCR Purification kit
(Qiagen). cDNA fragmentation and labeling were performed using
the NuGEN FL-Ovation cDNA Biotin Module V2 kit (NuGEN).
DNA microarray analysis
Array analysis was conducted on the Affymetrix Mouse
Genome 430 2.0 Array (Affymetrix, Santa Clara, CA) and
analyzed using the GeneSifter gene expression analysis suite
(Geospiza, Seattle, WA). Individual gene expression values were
normalized to the median. Significant changes in gene expression
between sample sets were identified by a Student’s t-test and
subsequent Benjamini–Hochberg correction, with a p-value of
0.05 as the criterion for statistical significance. All microarray data
are MIAME compliant and are deposited as ArrayExpress
accession E-MEXP-3231.
Quantitative real-time PCR
Differential gene expression was confirmed by quantitative real-
time polymerase chain reaction (qRT-PCR) using commercially
available primer-probe sets (Table S1, Applied Biosystems, Foster
City, CA). qRT-PCR was performed on a LightCycler 480 (Roche
Diagnostics).
Immunohistochemistry
Liver tissue samples from collagen-GFP mice were collected into
10% formalin. Immunohistochemistry was conducted by the Herbert
Irving Comprehensive Cancer Center Histology Service using
standard protocols. Desmin expression was localized using an anti-
desmin monoclonal mouse anti-human antibody at a dilution of
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1:400 (Dako, Carpinteria, CA, clone D33, IR606), and GFP was
localized using an anti-GFP rabbit polyclonal antibody at a dilution of
1:500 (Invitrogen, Carlsbad, CA, A-11122). Fluorescent images were
captured at 406 magnification using a Zeiss Axiovert 200 M
Microscope with Apotome (Zeiss, Göttingen, DE), and images were
taken using an AxioCam MRm camera (Zeiss).
Primary HSC culture
HSCs were isolated from WT and collagen-GFP mice as
described above. Approximately 0.56106 cells were resuspended
in DMEM containing 10% fetal bovine serum and 1% penicillin/
streptomycin, seeded on 35 mm glass bottom dishes (MatTek Co.,
Ashland, MA) and incubated at 37uC overnight. Phase contrast
and fluorescent images were captured using an FSX100 Olympus
Microscope (Olympus America Inc., Center Valley, PA).
Reverse-phase HPLC analysis
Liver and HSC retinyl ester levels were determined by
procedures described previously [10]. Briefly, 200 mg liver tissue
was homogenized in 2 ml of PBS (10 mM sodium phosphate,
pH 7.2, 150 mM sodium chloride) using a Polytron homogenizer
(Brinkmann Instruments, Westbury, NY) and 200 ml aliquots were
taken for further analysis. For HSCs, aliquots of 100,000 cells were
resuspended in 1 ml PBS. All samples were then treated with an
equal volume of absolute ethanol containing a known amount of
retinyl acetate as an internal standard, and the retinoids present in
the homogenates were extracted into hexane. The extracted
retinoids were separated on a 4.66250 mm Ultrasphere C18
column (Beckman, Fullerton, CA) preceded by a C18 guard column
(Supelco, Bellefonte, PA), using 70% acetonitrile, 15% methanol,
15% methylene chloride as the running solvent flowing at 1.8 ml/
min. Retinol and retinyl esters (retinyl palmitate, oleate, linoleate,
and stearate) were detected at 325 nm and identified by comparing
the retention times and spectral data of experimental compounds
with those of authentic standards. Concentrations of retinol and
retinyl esters in the tissues were quantitated by comparing
integrated peak areas for each retinoid against those of known
amounts of purified standards. Loss during extraction was
accounted for by adjusting for the recovery of the internal standard
added immediately after homogenization of the cells and tissues.
Triglyceride analysis
Approximately 200 mg of liver or 0.56106 HSCs were
homogenized in 1 ml of PBS using a Polytron homogenizer.
The lipids in the homogenates were then extracted into
chloroform:methanol (2:1 v/v), and the lower, chloroform phase
was collected. The upper phase was re-extracted with an
additional volume of chloroform:methanol to ensure complete
triglyceride recovery, and the pooled chloroform phases were
evaporated under N2. One milliliter of 2% Triton X-100 in
chloroform for liver or 50 ml for HSCs was then added to the
samples, and the chloroform was re-evaporated under N2. For
liver, triglycerides were solubilized for colorimetric assay through
addition of 1 mL of deionized water into the glass tubes.
Employing a Matrix Plus Chemistry Reference Standard (Ver-
ichem Laboratories Inc., Providence, RI), according to the
manufacturer’s instructions, a colorimetric triglyceride assay using
the Infinity Triglyceride Reagent (Thermo Fisher Scientific Inc.,
Middletown, VA) was performed in a 96-well plate for 5 ml of each
liver sample. For HSCs, 200 ml of Triglyceride Reagent was added
directly to the dried-down samples, and the entire volume was
read in the colorimetric assay. Color development was measured
on a Multiskan Plus Microtiter Plate Reader at 520 nm.
Western blot protein analysis
HSC proteins were analyzed by Western blot assay. For all
proteins analyzed, 5 mg of total protein was separated on 10%
Figure 1. Co-localization of GFP expression with expression of the HSC marker desmin. Immunohistochemistry was performed on
sections of liver from collagen-GFP mice using antibodies to the HSC marker desmin (A) and GFP (B). Merged image shows colocalization of desmin
and GFP expression (C). DAPI (blue) staining of nuclei is also shown in the merged image. Micrographs are at 406magnification. Scale bars, 15 mm.
Arrows point to a hepatic stellate cell. Insets show magnified view of one HSC.
doi:10.1371/journal.pone.0024993.g001






Student’s t-test 0.05 5363* 2676 2687
0.01 3563 1901 1662
0.001 1673 825 848
Welch’s t-test 0.05 5074 2361 2713
0.01 2674 1064 1610
0.001 985 230 755
Affymetrix Mouse 430 2.0 microarray chips were used to search for gene
expression differences between AF- and GFP-HSCs. Lists of differentially
expressed genes were generated using Student’s t-tests or Welch’s t-tests, each
with three p-value cut-offs, including 0.05, 0.01 and 0.001. For each comparison,
the number of total, increased and decreased differentially expressed genes is
shown.
*All further analysis conducted on this set of differentially expressed genes.
doi:10.1371/journal.pone.0024993.t001
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SDS–PAGE gels and transferred onto polyvinylidene fluoride
membrane (Millipore Immunobilon-P Transfer Membrane) at
100 V for 1 h at 4uC. The membranes were then incubated with
10% milk blocking buffer for 1 h at room temperature (RT),
followed by overnight incubation at 4uC with the following
primary antibodies: alpha smooth muscle actin (1:100, rabbit
polyclonal, Abcam, Cambridge, MA, ab5694), adipose differen-
tiation related protein (1:500, rabbit polyclonal, Abcam, ab52356),
CYP2S1 (1:500, rabbit polyclonal, Abcam, ab69650), CYP2E1
(1:500, rabbit polyclonal, Abcam, ab28146) and LRAT (1:500,
mouse monoclonal, gift from Dr. Krzysztof Palczewski, Depart-
ment of Pharmacology, Case Western Reserve University). The
secondary antibody incubations were for 1 h at RT with either a
donkey horseradish peroxidase-conjugated anti-rabbit IgG antise-
rum (1:10,000, GE Healthcare, Piscataway, NJ, cat# NA934V) or
goat horseradish peroxidase-conjugated anti-mouse IgG antiserum
(1:10,000, EMD Chemicals Inc., Gibbstown, NJ, cat# 401215).
Immunoblots were developed using the ECL system (Thermo
Scientific, Rockford, IL).
Statistical analysis
All data are presented as means 6 S.D. A Student’s t-test was used
to analyze for statistically significant differences between groups.
Groups were considered to be significantly different when p,0.05.
Results
Methods of HSC isolation
To obtain a relatively vitamin A-enriched population of HSCs,
we conducted FACS on HSCs obtained by conventional
Table 2. KEGG Pathway Enrichment.
z-score KEGG Pathway Gene Set Total Changed Up Down z-score
UP Cell adhesion molecules (CAMs) 131 51 34 17 5.64
Cytokine-cytokine receptor interaction 232 74 48 26 4.95
Leishmaniasis 66 30 19 11 4.72
Type I diabetes mellitus 44 19 14 5 4.50
Leukocyte transendothelial migration 114 44 26 18 4.16
ECM-receptor interaction 76 27 18 9 3.63
Maturity onset diabetes of the young 25 10 8 2 3.41
Steroid biosynthesis 17 6 6 0 3.25
Glycine, serine and threonine metabolism 30 9 8 1 2.80
DOWN Axon guidance 127 54 24 30 4.76
Focal adhesion 189 70 33 37 4.01
Gap junction 83 25 7 18 3.25
Cell cycle 123 27 4 23 2.89
ErbB signaling pathway 84 22 6 16 2.48
Chemokine signaling pathway 173 47 20 27 2.11
Tests of KEGG pathway enrichment were conducted on the set of 5363 differentially expressed genes identified by the Student’s t-test as having a p-value equal to or
less than 0.05. The tests were performed using the GeneSifter software. A pathway is defined as enriched if it has a positive z-score up or down greater than or equal to
2.
doi:10.1371/journal.pone.0024993.t002
Table 3. Markers of HSC Activation.
AFFY ID Gene Name Gene ID FC p-value
1449254_at Secreted phosphoprotein 1 Spp1 115.5 0.000001
1419123_a_at Platelet-derived growth factor, C polypeptide Pdgfc 39.3 0.002963
1449351_s_at Platelet-derived growth factor, C polypeptide Pdgfc 32.5 0.003461
1456658_at Actin, alpha 2, smooth muscle Acta2 5.5 0.001718
1456156_at Leptin receptor Lepr 4.2 0.007139
1451924_a_at Endothelin 1 Edn1 4.2 0.000544
1416454_s_at Actin, alpha 2, smooth muscle Acta2 3.5 0.016302
1438303_at Transforming growth factor, beta 2 Tgfb2 2.7 0.002149
1448729_a_at Septin 4 Sept4 0.49 0.003582
1443434_s_at Plexin C1 Plxnc1 0.45 0.000309
1455851_at Bone morphogenetic protein 5 Bmp5 0.40 0.000004
Differences in gene expression are reported as fold-change (FC) relative to AF-HSCs.
doi:10.1371/journal.pone.0024993.t003
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Nycodenz flotation of cells present in a pronase digest of a liver.
Vitamin A autofluoresces at 460 nm upon excitation at 350 nm,
so exposure to this excitation wavelength allowed us to collect a
population of cells that is enriched in vitamin A. This population
of lipid droplet- and vitamin A-enriched HSCs will be referred to
subsequently as AF-HSCs. The second method of HSC isolation
used in this study capitalizes on transgene GFP expression driven
by the Col1a1 promoter in these mice [16] and data indicating that
expression of collagen I in the liver occurs exclusively in the HSCs
[17,18]. We performed FACS on digests of non-parenchymal cells
and collected GFP-positive cells based on their excitation at
488 nm. This GFP-expressing population of HSCs will be referred
to as GFP-HSCs. To confirm that GFP expression is confined to
HSCs, we performed immunohistochemistry using antibodies to
GFP and the HSC marker desmin [23]. We show that GFP
expression is found only in the HSCs, with GFP expression co-
localizing with desmin expression, and is not found in the other
major cell types in the liver (Figure 1A–C). We further analyzed
the integrity of these populations by qRT-PCR using desmin
mRNA expression as a marker of HSC purity, and we show that
the two different methods of HSC isolation yield cell populations
with equivalent desmin expression (Figure S1A).
Microarray analysis overview
For this study, we performed gene microarray analysis on
populations of AF-HSCs isolated from 6 mice and GFP-HSCs
isolated from 5 mice. cDNA purified from these populations was
run on Affymetrix Mouse Genome 430 2.0 Arrays, covering over
45,000 transcripts in the mouse genome, and data was analyzed
using GeneSifter software. The quality of the samples used is
demonstrated by the box plot and scatter plot summaries of the AF
and GFP groups, which show that the spread of all the array data
points is identical in both groups (Figure S1B and S1C). Five
thousand three hundred sixty three probe sets were more than 2-
fold up- or down-regulated in the GFP-HSCs compared to AF-
HSCs (Table 1). As a second-stage filter and an analysis with
biological implications, the list of transcripts with significant
differential expression between AF- and GFP-HSCs was screened
against .200 known KEGG (Kyoto Encyclopedia of Genes and
Genomics) pathways. This analysis identified 15 KEGG pathways
where a significant number of genes were either up- or down-
regulated (Table 2). Significance at the pathway level was defined
as a z-score with an absolute value greater than 2. As described by
Walewski et al., a positive z-score greater than or equal to 2
indicates that a significant number of genes in the list of
differentially expressed genes are significantly up- or down-
regulated in the experimental group in that particular pathway
[24]. Notably, a number of the enriched KEGG pathways
identified by this study have a direct or indirect relationship with
the extracellular matrix (ECM), which is a target of deregulation in
HSCs that are in the early stages of activation [13]. These
pathways are classified as cellular adhesion molecules (CAMs),
ECM-receptor interaction, focal adhesions, and gap junctions
(Table 2).
GFP-HSCs are phenotypically similar to HSCs undergoing
early activation
As a result of activation, HSCs undergo increased collagen I
production and a simultaneous loss of their retinyl ester-containing
lipid droplets [18,19]. Because we have selected for a population of
HSCs that express Col1a1, we were interested in whether GFP-
HSCs would display characteristics of activated HSCs. The array
suggests that a number of markers of HSC activation are elevated
in the GFP-HSCs, including alpha smooth muscle actin (Acta2),
platelet-derived growth factor C (Pdgfc), transforming growth
factor beta 2 (Tgfb2), and endothelin (Edn1) (Table 3). Elevated
expression of all markers was confirmed by qRT-PCR; however,
only Acta2 up-regulation was found to be significant (Figure 2A).
Elevated protein levels of ACTA2 are also shown by western blot
analysis (Figure 2B).
The elevated levels of markers of HSC activation prompted us
to then examine whether the GFP-HSCs have less retinyl ester and
triglyceride, which are the two predominant lipid species present
in quiescent HSC lipid droplets [8]. We found that, while the livers
of the WT and collagen-GFP mice have comparable levels of both
lipid species (Figures 3A and 3C), the GFP-HSCs have
Figure 2. mRNA and protein expression of markers of HSC activation. (A) Relative mRNA expression levels of Col1a1, Acta2, Pdgfc, Tgfb, and
Edn1 in AF-HSCs (solid bars) and GFP-HSCs (stripped bars) are shown. Values are normalized to 18S and given as the mean 61 S.D. for 5 AF and 5 GFP
HSC isolations. Significance was determined by a Student’s t-test, *** p-value,0.001. ND means ‘‘not detected.’’ (B) Protein levels of ACTA2 in AF-
HSCs and GFP-HSCs. Experiment was repeated with similar results.
doi:10.1371/journal.pone.0024993.g002
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significantly less retinyl ester (Figure 3B) and triglyceride
(Figure 3D). To further assess lipid droplet content in these cells,
AF- and GFP-HSCs were isolated by FACS and cultured
overnight on glass plates. Lipid droplet quantity and size were
assessed by phase contrast and fluorescent microscopy (Figure 4A
and 4B). We found that GFP-HSCs have on average more lipid
droplets per cell than AF-HSCs (Figure 4C); however, these
droplets are smaller in size, determined by the average diameter of
lipid droplets per cell measured in microns (Figure 4D). We also
calculated the theoretical lipid droplet volume per cell, assuming a
lipid droplet is a perfect sphere. Total lipid droplet volume per cell
is the same in both populations (Figure 4E), and furthermore, the
Figure 3. Total retinyl ester and triglyceride levels in liver and HSCs. (A) Retinyl ester (RE) levels in livers from WT and collagen-GFP mice,
expressed as mg RE per gram liver weight. (B) Retinyl ester levels in AF-HSCs and GFP-HSCs, expressed as mg RE per million cells. (C) Triglyceride (TG)
levels in livers from WT and collagen-GFP mice, expressed as mg TG per gram liver weight. Mice were fasted for 4 hours prior to sacrifice and tissue
collection. (D) TG levels in AF-HSCs and GFP-HSCs, expressed as mg TG per million cells. Significance was determined by a Student’s t-test, * p-
value,0.05. (E) Protein levels of LRAT in AF-HSCs and GFP-HSCs. Experiment was repeated with similar results.
doi:10.1371/journal.pone.0024993.g003
Hepatic Stellate Cell Retinoid and Lipid Storage
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24993
lipid droplet-associated protein adipose differentiation related
protein (ADRP) is also expressed at equivalent levels in both AF-
and GFP-HSCs (Figure 4F).
Changes in retinoid- and lipid-related gene expression
To better understand the lower levels of retinyl ester and
triglyceride in GFP-HSCs, we focused our array analysis on retinoid-
and lipid-related gene expression. The retinoid and lipid nuclear
receptors were of high interest, as this group of genes represents a
major route of gene regulation with many downstream effectors. The
array data indicated that levels of the retinoid X receptor alpha (Rxra),
retinoic acid receptor alpha and gamma (Rara and Rarg) and the
peroxisome proliferator activated receptor alpha (Ppara) are lower in
GFP-HSCs (Table 4). However, qRT-PCR analysis did not confirm
significant differences in the expression of these genes in this
population of cells (Figure 5). Similarly, the array suggested
differential expression in the retinol- and fatty acid binding proteins,
specifically retinol binding protein (Rbp4), cellular retinol binding
Figure 4. Assessment of lipid droplet content in AF-HSCs and GFP-HSCs after overnight culture. AF-HSCs and GFP-HSCs were isolated by
FACS and incubated at 37uC overnight on glass bottom dishes. Phase contrast and fluorescent images were captured at 606magnification for both
AF-HSCs (A) and GFP-HSCs (B). Scale bars represent 30 mm. Average number of lipid droplets (C), average diameter (mm) of lipid droplets (D) and total
lipid droplet volume (mm3) (E) per HSC are shown. (F) Protein levels of ADRP in AF-HSCs and GFP-HSCs. Experiment was repeated with similar results.
doi:10.1371/journal.pone.0024993.g004
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protein 1 (Rbp1) and fatty acid binding protein 4 (Fabp4) (Table 5).
qRT-PCR analysis of mRNA levels confirmed that Fabp4 has
significantly higher expression in the GFP-HSCs (Figure 6). The
array additionally suggested that there may be significant gene
transcriptional changes relating to lipid metabolism underlying the
altered lipid content in the GFP-HSCs. There is elevated expression
of two triglyceride lipases, diacylglycerol lipase, beta (Daglb) (Table 6)
and arylacetamide deacetylase (Aadac) (Table 7). A number of
phospholipases exhibited higher expression in the GFP-HSCs,
including various members of the A and C subfamilies (Table 7).
Notably, the array showed that carboxylesterase 3 (Ces3) expression is
82-fold higher in the GFP-HSCs (Table 7), and this elevation was
confirmed by qRT-PCR of Ces3 mRNA levels (Figure 7). This is
interesting in light of the fact that a number of carboxylesterases have
been proposed to be hepatic retinyl ester hydrolases [25,26]. Also, we
found via qRT-PCR analysis that lipoprotein lipase (LpL) mRNA
expression is elevated in the GFP-HSCs (Figure 7).
Cytochrome-mediated retinoid catabolism
Since it is well established that HSC retinoids are lost upon cell
activation, we hypothesized that the lower levels of retinyl ester in
GFP-HSCs is a consequence of either increased mobilization of
retinol from the HSCs or increased retinoid catabolism within the
HSCs. Our data suggest that the first hypothesis is unlikely since we
observe no differential expression of the retinoid-binding proteins in
the GFP-HSCs (Figure 6), which are responsible for inter- and
intracellular transport of retinoid in the body. To investigate the
second hypothesis, we considered changes in gene expression in
cytochrome P450 enzymes. The cytochromes (CYPs) are known to
metabolize both exogenous compounds, including chemicals in the
environment, carcinogens and drugs, and also endogenous com-
pounds, including retinoids [27]. The array suggests that a number of
CYPs are differentially expressed in GFP-HSCs (Table 8). However,
we are specifically interested in CYPs that are known to metabolize
retinoids and/or are proposed to play a role in HSC activation. Of
the twenty five CYPs shown to be differentially expressed on the
array, two meet these criteria: Cyp2s1, which has 32-fold higher
expression in GFP-HSCs, and Cyp2e1, which has approximately 3-
fold higher expression in GFP-HSCs (Table 8). We confirmed
higher levels of Cyp2s1 and Cyp2e1 mRNA (Figure 8A) and in
CYP2S1 protein (Figure 8B) in GFP-HSCs compared to AF-HSCs.
CYP2E1 protein was unchanged (Figure 8B).
Figure 5. mRNA levels of retinoid- and lipid-related nuclear receptors. Relative mRNA expression levels of Rxra, Rara, Rarg, and Ppara in AF-
HSCs (solid bars) and GFP-HSCs (stripped bars) are shown. Values are normalized to 18S and given as the mean 61 S.D. for 5 AF and 5 GFP HSC
isolations.
doi:10.1371/journal.pone.0024993.g005
Table 4. Retinoid- and Lipid-related Nuclear Receptors.
AFFY ID Gene Name Gene ID FC p-value
1454773_at Retinoid X receptor alpha Rxra 0.5 0.005977
1450180_a_at Retinoic acid receptor, alpha Rara 0.4 0.002350
1419416_a_at Retinoic acid receptor, gamma Rarg 0.4 0.003971
1425762_a_at Retinoid X receptor alpha Rxra 0.4 0.000323
1439675_at Peroxisome proliferator activated receptor alpha Ppara 0.3 0.004452
Differences in gene expression are reported as fold-change (FC) relative to AF-HSCs.
doi:10.1371/journal.pone.0024993.t004
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CYP2S1 is a recently-identified cytochrome enzyme that has
been shown to be expressed highly in the lung, small intestine and
spleen and to be inducible by dioxin, which acts via the aryl
hydrocarbon receptor [28,29]. It has also been reported to both
metabolize and be induced by all-trans-retinoic acid [30]. The
literature does not definitively establish the expression of CYP2S1
in the liver; CYP2S1 expression has been detected in the liver,
albeit at very low levels [31,32]. More recently, CYP2S1 was
shown to be expressed in human HSCs [33]. To further elucidate
the expression of CYP2S1 in the mouse liver, we isolated both
hepatocytes and HSCs and measured mRNA levels of 6 CYPs,
which were chosen based on their known liver expression, roles in
retinoid metabolism and/or proposed roles in hepatic disease. We
found that while Cyp2e1 is more highly expressed in hepatocytes,
Cyp2s1 is highly enriched in HSCs (Figure 9A).
Having shown Cyp2s1 to be highly expressed in HSCs and
elevated in collagen-expressing HSCs relative to the non-collagen-
expressing population, we became interested in whether this
cytochrome might play a role in the early events of hepatic fibrosis,
when HSCs activate and lose their lipid droplet content. To
address this question, we injected WT C57 mice around 3 months
of age with either CCl4 (0.5 ml/g body weight) or corn oil vehicle
control once a week for 4 weeks and assessed changes in mRNA
expression of the 6 CYPs discussed above. Total hepatic retinol
(retinol+retinyl ester) levels are significantly decreased in mice
receiving CCl4 injections (Figure S2), confirming successful HSC
activation in these mice. We found that hepatic levels of Cyp26a1
and Cyp2s1 were both elevated when mice were treated with CCl4,
by approximately 4-fold in each case (Figure 9B). Thus, we
identify Cyp2s1 as the only retinoid-catabolizing CYP that is both
highly expressed in HSCs and induced in CCl4-mediated HSC
activation. We propose that CYP2S1 plays a role in the catabolism
of HSC retinoid content, contributing to the lower retinyl ester
and lipid droplet content in both collagen-expressing HSCs and
HSCs activated in vivo by CCl4 exposure.
Discussion
The idea that there is heterogeneity and plasticity in the HSC
population in the liver is not new, but has not previously been well-
studied. Studies in the early 1990s introduced this idea, utilizing
the HSC marker desmin to show that there is a population of
desmin-negative, lipocyte-like cells in the liver [34] and that these
HSCs are vitamin A-deficient [35]. Our study extends these earlier
reports and the proposition that not all HSCs in the liver are
equivalent by using different methodologies to isolate two distinct
populations of HSCs from the liver and to characterize their
morphological and biochemical properties. The different methods
of cell isolation we used take advantage of distinct properties of
these cells: the first method relies on HSC lipid droplet vitamin A
content and the second on HSC collagen I gene expression.
The standard method of HSC isolation employs a Nycodenz
density gradient to separate non-parenchymal cells from a liver
digest where hepatocytes have been destroyed by exposure to
pronase [9,21,22]. The low buoyant density of the numerous lipid
droplets present in the HSCs (see Figure 4) allows these cells to
float to the top of the gradient and thereby be separated from the
other less lipid-rich cell types present in the liver. To obtain a
vitamin A-enriched population of HSCs, we additionally conduct-
ed FACS on the nycodenz-purified cells. Vitamin A autofluoresces
upon excitation at 350 nm, so exposure to this wavelength of light
allowed us to collect a population of cells that is enriched in
vitamin A. We also employed a second FACS-based method to
isolate HSCs. This involved the use of collagen-GFP mice in which
GFP expression is driven by the Col1a1 promoter [16]. Our data
confirm that collagen I expression in the liver is confined to the
HSCs, with GFP expression co-localizing exclusively with desmin-
positive cells. Our data additionally show that the GFP-based
method of HSC isolation yields a population of cells with
equivalent desmin expression to the conventional Nycodenz-based
method. Thus, we demonstrate for the first time a novel method of
HSC isolation that yields cells of identical purity to cells isolated by
the conventional Nycodenz-based method.
When a liver is confronted with acute injury, a wound-healing
response is initiated which ultimately returns the liver to its healthy
state; however, when the liver is confronted with chronic injury,
the result is often hepatic fibrosis, which is the production of excess
fibrous connective tissue as a reparative process to contain the site
of injury [13,14]. In the early stages of hepatic fibrosis, the HSCs
undergo a process of activation, whereby they transition from a
quiescent, lipocyte-like state to a myofibrosblastic, contractile
phenotype. Activated HSCs express high levels of COL1a1 and
ACTA2, which are key components of the extracellular matrix.
Other key proliferative, fibrogenic and contractile stimuli in
hepatic fibrosis are PDGF-C, TGF-b and EDN1, respectively
[36]. Induction of ACTA2 is the single most reliable marker of
HSC activation because it is absent from other resident liver cells
Table 5. Retinol and Fatty Acid Binding Proteins.
AFFY ID Gene Name Gene ID FC p-value
1451263_a_at Fatty acid binding protein 4 Fabp4 10.9 0.001481
1417023_a_at Fatty acid binding protein 4 Fabp4 4.9 0.003252
1416022_at Fatty acid binding protein 5 Fabp5 3.4 0.002208
1426225_at Retinol binding protein 4 Rbp4 3.0 0.022103
1416021_a_at Fatty acid binding protein 5 Fabp5 2.8 0.000799
1450779_at Fatty acid binding protein 7 Fabp7 2.1 0.014394
1425105_at Retinol binding protein 3,
interstitial
Rbp3 0.5 0.024528
1448754_at Retinol binding protein 1, cellular Rbp1 0.5 0.010727
Differences in gene expression are reported as fold-change (FC) relative to AF-
HSCs.
doi:10.1371/journal.pone.0024993.t005
Figure 6. mRNA levels of retinol and fatty acid binding
proteins. Relative mRNA expression levels of Fabp4, Rbp4, and Rbp1
in AF-HSCs (solid bars) and GFP-HSCs (stripped bars) are shown. Values
are normalized to 18S and given as the mean 61 S.D. for 5 AF and 5
GFP HSC isolations.
doi:10.1371/journal.pone.0024993.g006
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in either normal or injured liver; furthermore, its expression
connotes a contractile phenotype [37]. Our data show that GFP-
HSCs have significantly elevated levels of both ACTA2 mRNA
and protein, indicating that this is a population of HSCs in early
activation. Because the livers from which these cells were isolated
were not experimentally injured or chemically induced, these
findings suggest that there is a population of pre-activated HSCs in
the liver under physiological conditions. This idea supports earlier
studies in transgenic mice, in which GFP was driven by the
collagen I promoter and red fluorescent protein (RFP) was driven
by the Acta2 promoter [38]. It was shown that there are mixed
populations of activated HSCs, such that some populations
expressed GFP or RFP alone and some expressed both. There
may be two explanations for this phenomenon. One possibility is
that these cells are partially activated in response to a local hepatic
insult, which could involve the natural microbiome (perhaps, the
gut flora) of the organism and elicitation of an LPS response;
alternatively, the HSC population in a healthy liver may be in
constant flux, such that there is a cyclical turn-over of quiescent
and activated HSCs. We believe that the second possibility is more
likely and that our finding that there exists a pre-activated
population of HSCs in a healthy liver reflects the dynamic
physiology of these cells, which ensures that there will always be a
subset of the population ready to respond to hepatic injury.
Lipid droplets are indispensable, metabolically active organelles
found ubiquitously across species (including plants, animals and
yeasts) and also within different animal cell types (adipocytes,
macrophages, hepatocytes, hepatic stellate cells, etc.) [39]. Thus,
lipid droplets are versatile and diverse. Lipid droplets found in
different cell types have different lipid and protein compositions.
Cell-specific localization combined with unique composition
dictates regulation of lipid droplet formation and maintenance in
a cell type-specific manner. There is a strong correlation between
the predominant lipid species in the droplet and the enzyme(s)
responsible for synthesis of the lipid. For instance, an adipocyte
lipid droplet, which is composed primarily of triglyceride
synthesized by DGAT1 (diacylglycerol acyltransferase 1) and/or
DGAT2, will not be formed when these two enzymes are not
expressed [40]. Similarly, the HSC lipid droplet has a unique
retinoid and lipid content, not found in other cell types in the body
[8,9]. The retinyl ester content is dependent on expression of
LRAT, which is the only hepatic enzyme capable of retinyl ester
synthesis in vivo [10]. We show that when LRAT expression is
diminished, these lipid droplets are smaller in size, suggesting
degradation. Importantly, it is also established that as HSCs
undergo activation, they lose their retinyl ester-containing lipid
droplets; though it is not known if this loss is a cause or
consequence of the activation process. Thus, our findings correlate
strongly with the events known to occur in the early stages of HSC
activation. LRAT expression is low, retinyl ester levels are
decreased, and there are marked alterations in the HSC lipid
droplets.
Our observations regarding the different lipid droplet content in
the GFP-HSCs additionally allows us to hypothesize about the
events taking place in the very early stages of HSC activation. It is
important to emphasize that the GFP-HSCs have not been
experimentally induced, so we distinguish these cells as ‘‘pre-
activated’’ HSCs: they are not fully activated, but they display
Table 6. Lipases.
AFFY ID Gene Name Gene ID FC p-value
1430550_at Lipase, family member M Lipm 6.1 0.047718
1452398_at Phospholipase C, epsilon 1 Plce1 3.9 0.000029
1417785_at Phospholipase A1 member A Pla1a 3.5 0.001223
1430700_a_at Phospholipase A2, group VII (platelet-activating factor acetylhydrolase,
plasma)
Pla2g7 3.5 0.002280
1457157_at Phospholipase C-eta1a Plch1 2.6 0.007681
1425338_at Phospholipase C beta 4 Plcb4 2.5 0.007491
1436821_at Phosphatidylinositol-specific phospholipase C, X domain containing 3 Plcxd3 2.4 0.031885
1437872_at NAPE-PLD mRNA for N-acyl-phosphatidylethanolamine-hydrolyzing
phospholipase D
Napepld 2.3 0.017539
1451970_at Diacylglycerol lipase, beta Daglb 2.3 0.011264
1435771_at Phospholipase C beta 4 Plcb4 2.1 0.002450
1448558_a_at Phospholipase A2, group IVA Pla2g4a 2.0 0.001474
1424259_at Lipase maturation factor 1 Lmf1 0.5 0.042273
1454619_at Lipase maturation factor 2 Lmf2 0.5 0.000238
1416013_at Phospholipase D family, member 3 Pld3 0.4 0.000290
1421261_at Lipase, endothelial Lipg 0.4 0.008316
1432928_at Phospholipase C, delta 4 Plcd4 0.4 0.039780
1450188_s_at Lipase, endothelial Lipg 0.4 0.002089
1455448_at Diacylglycerol lipase, alpha Dagla 0.4 0.000027
1417433_at Lysophospholipase 2 Lypla2 0.2 0.003292
1433949_x_at Soluble PLA2-Ib precursor Pla2g1b 0.2 0.018829
1450128_at Phospholipase A2, group IIA - 0.1 0.038422
Differences in gene expression are reported as fold-change (FC) relative to AF-HSCs.
doi:10.1371/journal.pone.0024993.t006
Hepatic Stellate Cell Retinoid and Lipid Storage
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24993
characteristic features of such cells, including decreased retinyl
ester levels and elevated expression of ACTA2 mRNA and
protein. A priori, we would expect the early events of HSC
activation to follow one of the following three scenarios: (i) lipid
droplets progressively decrease in number, eventually leading to
the complete loss of droplets; (ii) lipid droplets progressively
decrease in size, eventually leading to the complete loss of droplets;
or (iii) lipid droplets are initially broken-down into many more,
smaller droplets – increase in number, decrease in size - and then
they progressively decrease in number until none remain in the
cell. Interestingly, our data provide strong evidence for the third,
more complex scenario. We show that the GFP-HSCs, a
population of uninduced but collagen-expressing cells, have more
lipid droplets than the AF-HSCs, and these droplets are smaller in
size, as determined by a decrease in average diameter. Our data is
in good agreement with other studies investigating lipid droplet
dissolution in other cellular systems. It is known that in the first
several hours of hormone-stimulated lipolysis in 3T3-L1 adipo-
cytes, the lipid droplets present in these cells are fragmented and
dispersed into microlipid droplets, which significantly increases the
surface area available for lipase activity [41–43]. A similar pattern
of lipid droplet dissolution was reported for rat adipocytes, in
which lipolysis was stimulated by electroporation of a constitutively
active b-1 adrenergic receptor into the fat pads of the animals [44].
It will be necessary for future studies to confirm this sequence of
events in HSCs directly with real-time tracking of lipid droplet
remodeling in response to HSC activation. It will also be necessary
to define the contribution of the lipid droplet-associated proteins,
such as ADRP, to these processes. Our data shows ADRP protein
expression is not different in the GFP-HSCs, but its distribution in
the cell and on the lipid droplets might be changed as a
consequence of the beginning stages of lipolysis.
Our data also establish decreased triglyceride levels, along with
the differential expression of many lipid metabolism-related genes,
in GFP-HSCs. This is not surprising since triglyceride is the
second most predominant lipid species in HSC lipid droplets
Table 7. Esterases.
AFFY ID Gene Name Gene ID FC p-value
1449081_at Carboxylesterase 3 Ces3 82.2 0.000234
1421218_at Butyrylcholinesterase Bche 45.9 0.001056
1436090_at Ectonucleotide pyrophosphatase/phosphodiesterase 6 Enpp6 13.7 0.014343
1448813_at Arylacetamide deacetylase (esterase) Aadac 10.9 0.003532
1417300_at Sphingomyelin phosphodiesterase, acid-like 3B Smpdl3b 5.3 0.000398
1438665_at Sphingomyelin phosphodiesterase 3, neutral Smpd3 5.1 0.002101
1438785_at Ectonucleotide pyrophosphatase/phosphodiesterase 6 Enpp6 4.8 0.004224
1452202_at Phosphodiesterase 2A, cGMP-stimulated Pde2a 4.5 0.006551
1422779_at Sphingomyelin phosphodiesterase 3, neutral Smpd3 4.3 0.041569
1447707_s_at Phosphodiesterase 2A, cGMP-stimulated - 3.6 0.026599
1416913_at Esterase 1 Es1 3.4 0.044153
1417626_at Phosphodiesterase 4D interacting protein - 2.8 0.001982
1448136_at Ectonucleotide pyrophosphatase/phosphodiesterase 2 Enpp2 2.8 0.004744
1424150_at Glycerophosphodiester phosphodiesterase domain containing 5 Gdpd5 2.6 0.030611
1451857_a_at Notum pectinacetylesterase homolog Notum 2.5 0.015403
1417667_a_at Phosphotriesterase related Pter 2.4 0.000644
1427302_at Ectonucleotide pyrophosphatase/phosphodiesterase 3 Enpp3 2.3 0.000140
1415894_at Ectonucleotide pyrophosphatase/phosphodiesterase 2 Enpp2 2.2 0.001248
1437341_x_at 29,39-cyclic nucleotide 39 phosphodiesterase - 0.5 0.000609
1431913_a_at Phosphodiesterase 3A, cGMP inhibited - 0.5 0.000050
1435096_at Resistance to inhibitors of cholinesterase 8 homolog B Ric8b 0.5 0.001273
1422635_at Acetylcholinesterase Ache 0.5 0.004425
1437989_at Phosphodiesterase 8B - 0.5 0.000826
1421353_at CAMP specific phosphodiesterase 7B Pde7b 0.4 0.015231
1423810_at Protein phosphatase methylesterase 1 Ppme1 0.4 0.000273
1418302_at Palmitoyl-protein thioesterase 2 Ppt2 0.4 0.000061
1452897_at Cell division cycle 2-like 5 (cholinesterase-related cell division controller) Cdc2l5 0.4 0.000532
1421535_a_at Phosphodiesterase 4A, cAMP specific Pde4a 0.4 0.002163
1432490_a_at Phosphodiesterase 10A - 0.4 0.046869
1450453_a_at CGMP-phosphodiesterase 6 gamma subunit Pde6g 0.4 0.035910
1442700_at Phosphodiesterase 4B, cAMP specific Pde4b 0.4 0.000132
1451615_at Carboxylesterase 8 Ces8 0.3 0.012629
Differences in gene expression are reported as fold-change (FC) relative to AF-HSCs.
doi:10.1371/journal.pone.0024993.t007
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Table 8. Cytochrome P450 enzymes.
AFFY ID Gene Name Gene ID FC p-value
1416612_at Cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 100.9 0.000175
1428283_at Cytochrome P450, family 2, subfamily s, polypeptide 1 Cyp2s1 32.0 0.004925
1460604_at Cytochrome b reductase 1 Cybrd1 23.6 0.000016
1421075_s_at Cytochrome P450, family 7, subfamily b, polypeptide 1 Cyp7b1 17.1 0.000044
1417507_at Cytochrome b-561 Cyb561 13.2 0.000421
1421074_at Cytochrome P450, family 7, subfamily b, polypeptide 1 Cyp7b1 10.2 0.000009
1425040_at Cytochrome b reductase 1 Cybrd1 9.2 0.000095
1416613_at Cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 8.9 0.000029
1419559_at Cytochrome P450, family 4, subfamily f, polypeptide 14 Cyp4f14 8.4 0.000002
1422533_at Cytochrome P450, family 51 Cyp51 4.7 0.000374
1436778_at Cytochrome b-245, beta polypeptide Cybb 4.4 0.000743
1422978_at Cytochrome b-245, beta polypeptide Cybb 4.0 0.001173
1444138_at Cytochrome P450, family 2, subfamily r, polypeptide 1 Cyp2r1 3.9 0.016331
1436779_at Cytochrome b-245, beta polypeptide Cybb 3.8 0.003131
1450646_at Cytochrome P450, family 51 Cyp51 3.4 0.001651
1415994_at Cytochrome P450, family 2, subfamily e, polypeptide 1 Cyp2e1 2.9 0.006021
1422534_at Cytochrome P450, family 51 Cyp51 2.8 0.010709
1418780_at Cytochrome P450, family 39, subfamily a, polypeptide 1 Cyp39a1 2.2 0.038740
1418709_at Cytochrome c oxidase, subunit VIIa 1 Cox7a1 2.1 0.017825
1440211_at Cytochrome P450, family 2, subfamily j, polypeptide 11 Cyp2j11 0.5 0.026833
1416933_at P450 (cytochrome) oxidoreductase Por 0.5 0.002868
1430452_at Cytochrome P450, family 20, subfamily A, polypeptide 1 Cyp20a1 0.5 0.000408
1416112_at Cytochrome c oxidase, subunit VIIIa Cox8a 0.4 0.000037
1450752_at Cytochrome c, testis Cyct 0.3 0.011154
1425645_s_at Cyp2b10-like pseudogene Cyp2b10 0.3 0.040338
Differences in gene expression are reported as fold-change (FC) relative to AF-HSCs.
doi:10.1371/journal.pone.0024993.t008
Figure 7. mRNA levels of lipid hydrolases. Relative mRNA expression levels of Ces3 and LpL in AF-HSCs (solid bars) and GFP-HSCs (stripped bars)
are shown. Values are normalized to 18S and given as the mean 61 S.D. for 5 AF and 5 GFP HSC isolations. Significance was determined by a
Student’s t-test, * p-value,0.05 and ** p-value,0.01.
doi:10.1371/journal.pone.0024993.g007
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(31.7%), only slightly less than retinyl ester (39.5%) [8,9]. It is likely
that when retinyl esters are lost as a result of activation, the HSC
lipid droplet is targeted and signaled to breakdown, and thus,
synthesis of the non-retinoid lipids is down-regulated. This is
analogous to the idea discussed above that when the predominant
lipid found in a particular droplet is not synthesized, the droplet
will not form. In the case of the GFP-HSCs we are studying, some
retinyl ester is still being made since LRAT is still expressed; thus,
the droplets are present, but they are smaller in size. The decrease
in HSC triglyceride levels could be a consequence of either
decreased triglyceride synthesis or increased triglyceride catabo-
lism. The array data suggest that triglyceride synthesis is not
markedly different in the GFP-HSCs. There are no genes involved
in triglyceride biosynthesis with significant differential expression
in the GFP-HSCs. DGAT1 and DGAT2 are known triglyceride
synthesizing enzymes in the liver [45,46], but expression levels of
both are the same in the two HSC populations (data not shown).
There are, however, many differences in expression in genes
involved with triglyceride breakdown, classified as either lipases or
esterases. We observe increased expression of two triglyceride
lipases and a number of phopholipases. Phospholipids comprise
approximately 6% of lipids in HSC lipid droplets [8,9]; thus, the
increase in phopsholipid catabolism supports the idea that when
retinyl ester is low, the non-retinoid lipids are degraded, as well.
We also observe a large increase in expression of Ces3. This is
interesting in light of the fact that other carboxylesterases have
recently been proposed as potential retinyl ester hydrolases in
HSCs, including ES-4 and -10 [47,48]. Our findings suggest that
Ces3 might be a retinyl ester hydrolase in activated HSCs, but
more work will need to be done to confirm its HSC expression and
role in retinyl ester hydrolysis. Similarly, we find elevated levels of
LpL in the GFP-HSC population. Mello et al. have shown that
LpL is expressed at very low levels in hepatocytes and HSCs, but
its expression is induced 32-fold in activated HSCs [47]. Thus, the
elevated levels of LpL provide further evidence that the GFP
population are pre-activated HSCs. Overall, the highly altered
lipid metabolism in the GFP-HSCs is very interesting since we still
do not know much about the specific lipid species that populate
HSC lipid droplets, particularly with regard to the exact fatty acyl
compositions of the lipids in these cells. All we currently have is a
fairly crude understanding of the breakdown of retinyl ester,
triglyceride, cholesterol, phospholipids, and free fatty acids [8,9].
Thus, future work in this area will prove to be very exciting with
the potential of using the newly-emerging field of lipidomics and
the use of LC/MS/MS for these characterizations.
The cytochrome P450’s are a superfamily of enzymes known to
metabolize both exogenous compounds, including chemicals in the
environment, carcinogens and drugs, and also endogenous
compounds, including retinoids [27]. We were interested in
studying six cytochromes in particular, based on either their
expression in the liver and/or proposed roles in different types of
liver disease. The CYP26s (including CYP26A1, B1 and C1) are
thought to be the major retinoid-catabolizing CYPs in the body
[49–52]. They are known to metabolize all-trans-retinoic acid and
additionally, to be retinoic acid-inducible. CYP26A1 and B1 are
expressed in the mouse liver, but C1 is not. CYP2E1 is notable for
its role in alcoholic liver disease and for its release of reactive
oxygen species, which are known to promote fibrogenesis in HSCs
[53,54]. CYP2S1 is a relatively newly-identified CYP and thus is
not well-studied; however, it has been reported to metabolize
retinoic acid [28–30]. The last two, CYPs 2C37 and 2C39, have
liver-specific expression [55]. Additionally, 2C39 has been
reported to metabolize retinoic acid [56]. Of these six CYPs, only
CYP2S1 was shown on the array, by qRT-PCR and by western
blot to be elevated in the GFP-HSCs. Previous reports in the
literature suggest that CYP2S1 has very low expression in the liver
[31,32]. Our data show that Cyp2s1 is highly enriched in the
HSCs, which comprise only 6–8% of cells in the liver and contain
1% of hepatic protein [6,37]. Thus, expression in whole liver
homgenates will be masked by the presence of hepatocytes,
Figure 8. mRNA and protein expression of retinoid-metabolizing cytochrome P450 enzymes. (A) Relative mRNA expression levels of
Cyp2s1 and Cyp2e1 in AF-HSCs (solid bars) and GFP-HSCs (stripped bars) are shown. Values are normalized to 18S and given as the mean 61 S.D. for 5
AF and 5 GFP HSC isolations. Significance was determined by a Student’s t-test, ** p-value,0.01. (B) Protein levels of CYP2S1 and CYP2E1 in AF-HSCs
and GFP-HSCs. Experiments were repeated with similar results.
doi:10.1371/journal.pone.0024993.g008
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Kupffer cells and endothelial cells. Furthermore, we show that
Cyp2s1 expression is elevated in vivo by carbon tetrachloride-
mediated induction of hepatic fibrosis. Thus, we propose that
CYP2S1-mediated retinoid catabolism may play a role in the loss
of lipid droplets and retinyl ester content in HSCs undergoing
activation in the early stages of hepatic fibrosis.
In conclusion, using FACS-based methods of HSC isolation, we
show that there are distinct populations of HSCs in a normal mouse
Figure 9. Cyp2s1 is a retinoid-catabolizing CYP both highly expressed in HSCs and induced in hepatic fibrosis. (A) HSCs and
hepatocytes were isolated from male WT C57 mice at 3 months age. Relative mRNA expression levels of Cyp26a1, Cyp2e1, Cyp2c37, and Cyp2c39 (left
panel) and Cyp26b1 and Cyp2s1 (right panel) are shown. (B) WT C57 male mice were given weekly injections of either corn oil or 0.5 ul CCl4/g B.W.
administered in corn oil for 4 weeks and then sacrificed. Relative Cyp mRNA levels in whole liver homogenates were measured. Values are normalized
to 18S and given as the mean 61 S.D. Significance was determined by a Student’s t-test, * p-value,0.05, ** p-value,0.01, *** p-value,0.001.
doi:10.1371/journal.pone.0024993.g009
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liver. The GFP-isolated HSCs have altered lipid droplet content and
display distinct biochemical properties, determined by differential
gene and protein expression profiles and differential capacities for
retinyl ester and triglyceride storage in their lipid droplets.
Specifically, we show that the GFP-HSCs have: (i) increased
expression of typical markers of HSC activation; (ii) significantly
decreased retinyl esters, accompanied by reduced LRAT protein
expression; (iii) significantly less triglycerides; (iv) increased expres-
sion of genes associated with lipid catabolism, i.e. hydrolases and
esterases; and (v) an increase in expression of the retinoid-
catabolizing CYP, CYP2S1. Our data suggest that there is
heterogeneity in the HSC population in normal, uninjured liver.
A subset of the HSC population may serve as ‘‘primers’’ for
activation, such that they are the first responders in an injured liver.
Supporting Information
Figure S1 Quality assessment of samples used in
microarray analysis. Gene microarray analysis was conducted
on populations of AF-HSCs isolated from 6 mice and GFP-HSCs
isolated from 5 mice. cDNA purified from these populations was
run on Affymetrix Mouse Genome 430 2.0 Arrays, and data was
analyzed using GeneSifter software. (A) Levels of desmin mRNA
normalized to 18S. A Student’s t-test was used to analyze for
statistically significant differences between groups. Groups were
considered to be significantly different when p,0.05. (B) Boxplot
summary showing the maximum and minimum values, 1st and 3rd
quartiles, and medians of the AF and GFP groups. (C) Scatter plot
summary showing the spread of the data points around the line of
identity. All genes over-expressed in the GFP group are shown in
red; genes over-expressed in the AF group are shown in green.
(TIF)
Figure S2 Total retinol levels in the liver of mice treated
with CCl4. WT C57 male mice were given weekly injections of
either corn oil or 0.5 ul CCl4/g B.W. administered in corn oil for
4 weeks and then sacrificed. Total retinol (retinol+retinyl ester)
levels are shown, expressed as nmol total retinol per gram of liver.
Significance was determined by a Student’s t-test, * p-value,0.05.
(TIF)
Table S1 ABI primers used for qRT-PCR analysis. Commer-
cially available primers purchased from Applied Biosystems (ABI)
are shown with the ABI accession number for all genes qRT-PCR
analysis was conducted on.
(DOC)
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